The pharmaceutical industry fears major legislation that would curb prices and shrink profits, and has launched campaigns against it—but how honest are their claims?
The most recent new treatment for Alzheimer’s disease was approved by European regulators in May 2002, with the US FDA following suit the next year.
Recent lawsuits are asking courts whether the current crisis is comparable to the one over tobacco in the ’90s.
The possibility of curing sepsis with a common vitamin has put one of history’s greatest killers back in the spotlight.
Scientists invented chemical weapons; some are now working to destroy them.
A new study found that Big Pharma makes more from high U.S. drug prices than it spends on research around the world.
There are few new drugs on the horizon for diabetes, which affects about 29 million Americans.
Enormous technological changes are heading our way and they will transform pharma.